Pacific Biosciences Of California reported $258.24M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US -69750000 3.39M
Agilent A:US $ 4946M 136M
Bruker BRKR:US $ 1015.4M 47.7M
Danaher DHR:US $ 42756M 2337M
Fluidigm FLDM:US $ 109.45M 13.49M
General Electric GE:US $ 33487M 98M
Genmark Diagnostics GNMK:US $ 94.2M 0.24M
Illumina ILMN:US $ 5180M 258M
Luminex LMNX:US $ 488.05M 29.66M
Myriad Genetics MYGN:US $ 902.5M 27.3M
Nanostring Technologies NSTG:US $ 219.73M 16.66M
Oxford Immunotec Global OXFD:US $ 191.26M 2.37M
Pacific Biosciences Of California PACB:US $ 258.24M 22.31M
Perkinelmer PKI:US $ 4239.81M 237.5M
Quidel QDEL:US $ 1411.08M 78.64M
Thermo Fisher Scientific TMO:US $ 36854M 1796M
Waters WAT:US $ 268.27M 37.31M